SPOTLIGHT -
Double Trouble: Assessing the Impact of Combining Daptomycin and Fosfomycin for MRSA Bacteremia
This highlighted study looks at using these 2 therapies concurrently for this infection.
Read More
Piperacillin/Tazobactam for the Treatment of ESBL Pyelonephritis: A Redemption Arc
Interests have recently skewed toward the use of carbapenem-sparing regimens in light of growing selection for carbapenem-resistant organisms.
Differences in C difficile Diagnostics Blunt the Benefits of Bezlotoxumab
Bezlotoxumab, a human monoclonal anti­body directed against Clostridioides diffi­cile toxin B, is currently indicated for the prevention of recurrent C diffi­cile infection